Cargando…
Do anti-amyloid beta protein antibody cross reactivities confound Alzheimer disease research?
BACKGROUND: Alzheimer disease (AD) research has focussed mainly on the amyloid beta protein (Aβ). However, many Aβ-and P3-type peptides derived from the amyloid precursor protein (APP) and peptides thought to derive from Aβ catabolism share sequence homology. Additionally, conformations can change d...
Autores principales: | Hunter, Sally, Brayne, Carol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5270220/ https://www.ncbi.nlm.nih.gov/pubmed/28126004 http://dx.doi.org/10.1186/s12952-017-0066-3 |
Ejemplares similares
-
Erratum to: Do anti-amyloid beta protein antibody cross reactivities confound Alzheimer disease research?
por: Hunter, Sally, et al.
Publicado: (2017) -
Human antibodies reactive with beta-amyloid protein in Alzheimer's disease
Publicado: (1993) -
Amyloid in the ageing brain: New frameworks and perspectives
por: Hunter, Sally, et al.
Publicado: (2021) -
Relationships between the amyloid precursor protein and its various proteolytic fragments and neuronal systems
por: Hunter, Sally, et al.
Publicado: (2012) -
Using multielectrode arrays to investigate neurodegenerative effects of the amyloid-beta peptide
por: Schulte, Steven, et al.
Publicado: (2021)